Literature DB >> 1954391

Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin.

E Juvonen1, E Ikkala, F Fyhrquist, T Ruutu.   

Abstract

We describe here a family with autosomal dominant erythrocytosis. In in vitro cultures, performed using the methyl cellulose assay, the number of erythroid colonies was normal or marginally increased when a standard concentration of erythropoietin (Epo) was used, but at lower Epo concentrations, the investigated persons formed more colonies than the controls. The difference was generally greater the lower the Epo concentration became. Some erythroid colony growth was seen even in the absence of any added Epo (apart from the minute concentration found in fetal calf serum), a phenomenon not seen in the controls. This finding indicates that the erythrocytosis in this family is caused by hypersensitivity of erythroid progenitors to Epo. The serum Epo concentration was low or low normal in all of the investigated family members, which is in good accordance with hypersensitivity to Epo. The erythrocytosis has not had any obvious effect on the health or life-span of the affected individuals. Many of them have reached an advanced age, and one of the affected family members has won several Olympic gold medals and world championships in endurance sports.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1954391

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  21 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Regulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needs.

Authors:  Michael J Joyner; Darren P Casey
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 3.  Red blood cell volume and the capacity for exercise at moderate to high altitude.

Authors:  Robert A Jacobs; Carsten Lundby; Paul Robach; Max Gassmann
Journal:  Sports Med       Date:  2012-08-01       Impact factor: 11.136

Review 4.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

5.  Familial polycythemia due to truncations of the erythropoietin receptor.

Authors:  B G Forget; B A Degan; M O Arcasoy
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

6.  Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice.

Authors:  Beat Schuler; Margarete Arras; Stephan Keller; Andreas Rettich; Carsten Lundby; Johannes Vogel; Max Gassmann
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

Review 7.  Advances in understanding the pathogenesis of primary familial and congenital polycythaemia.

Authors:  Lily J Huang; Yu-Min Shen; Gamze B Bulut
Journal:  Br J Haematol       Date:  2010-01-20       Impact factor: 6.998

Review 8.  Erythropoiesis-stimulating agents and other methods to enhance oxygen transport.

Authors:  S Elliott
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

9.  Absence of polycythemia in a child with a unique erythropoietin receptor mutation in a family with autosomal dominant primary polycythemia.

Authors:  R Kralovics; L Sokol; J T Prchal
Journal:  J Clin Invest       Date:  1998-07-01       Impact factor: 14.808

10.  Genetic test for the personalization of sport training.

Authors:  Zakira Naureen; Marco Perrone; Stefano Paolacci; Paolo Enrico Maltese; Kristjana Dhuli; Danjela Kurti; Astrit Dautaj; Roberta Miotto; Arianna Casadei; Bernard Fioretti; Tommaso Beccari; Francesco Romeo; Matteo Bertelli
Journal:  Acta Biomed       Date:  2020-11-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.